Endoglin is an accessory protein that interacts with the signaling receptor complex of multiple members of the transforming growth factor-beta superfamily
- PMID: 9872992
- DOI: 10.1074/jbc.274.2.584
Endoglin is an accessory protein that interacts with the signaling receptor complex of multiple members of the transforming growth factor-beta superfamily
Abstract
Endoglin (CD105) is a transmembrane glycoprotein that binds transforming growth factor (TGF)-beta1 and -beta3, and coprecipitates with the Ser/Thr kinase signaling receptor complex by affinity labeling of endothelial and leukemic cells. The present study shows that in addition to TGF-beta1 and -beta3, endoglin interacts with activin-A, bone morphogenetic protein (BMP)-7, and BMP-2 but requires coexpression of the respective ligand binding kinase receptor for this association. Endoglin cannot bind ligands on its own and does not alter binding to the kinase receptors. It binds TGF-beta1 and -beta3 by associating with the TGF-beta type II receptor and interacts with activin-A and BMP-7 via activin type II receptors, ActRII and ActRIIB, regardless of which type I receptor partner is coexpressed. However, endoglin binds BMP-2 by interacting with the ligand binding type I receptors, ALK3 and ALK6. The formation of heteromeric signaling complexes was not altered by the presence of endoglin, although it was coprecipitated with these complexes. Endoglin did not interact with BMP-7 through complexes containing the BMP type II receptor, demonstrating specificity of its action. Our data suggest that endoglin is an accessory protein of multiple kinase receptor complexes of the TGF-beta superfamily.
Similar articles
-
Assignment of transforming growth factor beta1 and beta3 and a third new ligand to the type I receptor ALK-1.J Biol Chem. 1999 Apr 9;274(15):9984-92. doi: 10.1074/jbc.274.15.9984. J Biol Chem. 1999. PMID: 10187774
-
Endoglin differentially modulates antagonistic transforming growth factor-beta1 and BMP-7 signaling.J Biol Chem. 2007 May 11;282(19):13934-43. doi: 10.1074/jbc.M611062200. Epub 2007 Mar 21. J Biol Chem. 2007. PMID: 17376778
-
Extracellular and cytoplasmic domains of endoglin interact with the transforming growth factor-beta receptors I and II.J Biol Chem. 2002 Aug 9;277(32):29197-209. doi: 10.1074/jbc.M111991200. Epub 2002 May 15. J Biol Chem. 2002. PMID: 12015308
-
Bone morphogenetic proteins.Growth Factors. 2004 Dec;22(4):233-41. doi: 10.1080/08977190412331279890. Growth Factors. 2004. PMID: 15621726 Review.
-
Structural studies of the TGF-βs and their receptors - insights into evolution of the TGF-β superfamily.FEBS Lett. 2012 Jul 4;586(14):1860-70. doi: 10.1016/j.febslet.2012.05.028. Epub 2012 May 28. FEBS Lett. 2012. PMID: 22651914 Review.
Cited by
-
Intertwining of Activin A and TGFβ Signaling: Dual Roles in Cancer Progression and Cancer Cell Invasion.Cancers (Basel). 2014 Dec 30;7(1):70-91. doi: 10.3390/cancers7010070. Cancers (Basel). 2014. PMID: 25560921 Free PMC article. Review.
-
A murine model of hereditary hemorrhagic telangiectasia.J Clin Invest. 1999 Nov;104(10):1343-51. doi: 10.1172/JCI8088. J Clin Invest. 1999. PMID: 10562296 Free PMC article.
-
Endoglin Modulates TGFβR2 Induced VEGF and Proinflammatory Cytokine Axis Mediated Angiogenesis in Prolonged DEHP-Exposed Breast Cancer Cells.Biomedicines. 2022 Feb 10;10(2):417. doi: 10.3390/biomedicines10020417. Biomedicines. 2022. PMID: 35203627 Free PMC article.
-
Identification of CD105 (endoglin) as novel risk marker in CLL.Ann Hematol. 2022 Apr;101(4):773-780. doi: 10.1007/s00277-022-04756-4. Epub 2022 Jan 19. Ann Hematol. 2022. PMID: 35044512 Free PMC article.
-
Endoglin promotes TGF-β/Smad1 signaling in scleroderma fibroblasts.J Cell Physiol. 2011 Dec;226(12):3340-8. doi: 10.1002/jcp.22690. J Cell Physiol. 2011. PMID: 21344387 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases